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willingness to prescribe long-acting opioids. Two-thirds of the
family physicians were willing to prescribe long-acting opioids
for moderate to severe CNMP. However, attitudinal barriers
exist among those physicians unwilling to prescribe. Educational
interventions should focus on these barriers.
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PRESCRIBING OF FENTANYL PATCHES TO NON-OPIOID
TOLERANT PATIENTS IN THE MILITARY HEALTH 
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Trice S, Meade DJ, Napier J, Liss J,Tiller KW
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OBJECTIVES: As a result of safety concerns, labeling for fen-
tanyl patches was strengthened in June 2005 to limit use to
opioid-tolerant patients only. We evaluated prior opioid use in
MHS patients prescribed fentanyl patches to support the DoD
Pharmacy & Therapeutics Committee decision-making process.
METHODS: Study patients included all MHS patients newly
started on fentanyl patch from Jan–Dec 05 (no fentanyl patch
prescription ≤180 days prior to index date). Patients were
assumed to be opioid-tolerant based on prescriptions for a
deﬁned set of opioids considered potentially equipotent to a
starting dose of fentanyl patch (25 mcg/hr) ﬁlled during 45–60
days prior to their index date, or if hospitalized on or during
7–14 days prior to their index date (since opioids might have
been started during hospitalization). We did not estimate cumu-
lative dose or duration of opioids. Duration of “look-back”
periods and the deﬁned set of opioids were varied to provide
information on prescribing patterns. Prescription data were
obtained from DoD’s Prescription Data Transaction Service Data
Warehouse, hospitalization data from the MHS Management
Analysis and Reporting Tool. RESULTS: The percentage of
patients that could not be assumed to be opioid-tolerant prior to
starting fentanyl patch ranged from 27% to 51%; it was most
sensitive to changes in how potentially equipotent opioids were
deﬁned. Results from 3-month periods before (January–March
2005) and after (October–December 2005) labeling changes
were similar. CONCLUSION: The number of MHS patients who
are not opioid-tolerant prior to starting fentanyl patches is
potentially large. Assessments of changes in prescribing behav-
ior following educational efforts are underway. DoD decided in
January 2007 to require prior authorization for fentanyl patches,
based on prior opioid use.
PAIN—Patient-Reported Outcomes
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OBJECTIVES: To assess the sensitivity of the EQ-5D in differ-
entiating between severities of pain related health status (PRHS).
METHODS: Study is being conducted with chronic pain patients
attending a specialty pain centre in Edmonton, Alberta, Canada.
Self reported PRHS was determined using standardized clinical
measures that included the Pain Disability Index and The Facial
Pain Scale. These measures were slightly modiﬁed to facilitate
comprehension based on information generated from pilot
testing. Patients were categorized according to their PRHS and
the EQ-5D was administered to quantify their health utility.
Linear regressions were used to compare health utilities between
severity levels of PHS adjusting for gender, marital status, age,
month as a patient, smoking status and income. RESULTS:
Sixty-four patients have been assessed. The mean utility was
0.5524 (n = 30) for persons with moderate disability and severe
pain (MDSP), 0.3625 (n = 9) for persons with severe disability
and extreme pain (SDEP), 0.3358 (n = 22) for persons with
severe disability and severe pain (SDSP), and 0.2965 (n = 3) for
persons with moderate disability and extreme pain (MDEP).
Compared to persons with MDSP, persons with SDSP were asso-
ciated with a −0.225 utility decrement (p < 0.001), and persons
with SDEP associated with a −0.240 utility decrement (p =
0.002). All other comparisons between PRHS levels were non-
signiﬁcant. CONCLUSION: The EQ-5D may be sensitive in
detecting differences between low and high levels of PRHS but
not within severe levels of PRHS.
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OBJECTIVES: Brief Pain Inventory (BPI) is a self-administered
questionnaire used to assess severity and impact of pain on daily
functions. Developed for use in cancer pain, it is now being
widely used in assessment of both malignant and non-malignant
pain. To date, no published studies exist summarizing BPI’s psy-
chometric properties for both types of pain. The study objective
was to examine the existing evidence of the psychometric prop-
erties of BPI use in patients suffering from either type of pain.
METHODS: A structured literature review was performed to
summarize the psychometric properties of the BPI questionnaire
in both malignant and non-malignant pain. Published papers and
abstracts were retrieved by searching Medline 1983–2006,
SciSearch and pain-related websites. Relevant articles cited from
these search ﬁndings were also reviewed. Key search terms
included: Brief Pain Inventory, reliability, responsiveness and
validity. Articles were included for critical review if psychomet-
ric properties were addressed. RESULTS: Of 202 citations, 22
met inclusion criteria for critical review. Factor analysis 
was used to establish construct validity, which generated 2-items:
intensity and interference. Only one study reported 3-items 
by separating the interference domain by psychological func-
tions/sleep and physical function. Face and content validity were
demonstrated for both types of pain. Studies conducting longi-
tudinal analysis showed BPI scales were sensitive to change and
able to discriminate among groups of patients based on condi-
tion-speciﬁc measures of improvement, no change, or a decline.
Intraclass correlation coefﬁcient for test-retest reliability was
found to range from 0.61–0.76 for pain intensity and 0.81–0.88
for pain interference in malignant- pain. Internal consistency
coefﬁcients were approximately 0.85 for the intensity scale and
0.88 for the interference scale with the Cronbach’s alpha coefﬁ-
cients ranging from 0.77–0.95 for non-malignant pain. CON-
CLUSION: Evidence supports the use of the BPI as a reliable 
and valid pain assessment tool in malignant and non-malignant
pain.
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OBJECTIVES: Iatrogenic chronic pain is increasingly recognized
as a major adverse outcome after inguinal hernia repair. In order
to assess chronic post-herniorrhaphy pain, we developed the 18-
item Inguinal Pain Questionnaire (IPQ). The aim of the present
study was to test its validity and reliability and explore the preva-
lence of long term pain as determined by the questionnaire in a
sample from the population-based Swedish Hernia Register.
METHODS: Validity was tested in 100 patients who received
the IPQ and the Brief Pain Inventory (BPI) 1 and 4 weeks after
surgery (Group A). The reliability was tested in 100 patients who
received the IPQ on two occasions one month apart 3 years after
operation (Group B). From the Swedish Hernia Register 2853
operated 2000 were requested to ﬁll in IPQ by mail. RESULTS:
As an indication of construct validity, a signiﬁcant (p < 0.001)
decrease in IPQ-rated pain intensity was observed in the ﬁrst 4
weeks after surgery. Signiﬁcant (p < 0.05) correlations with cor-
responding BPI pain intensity items corroborated the criterion
validity. The rate of logical incoherence did not exceed 5.5% for
any item. Kappa values in the test-retest one month apart in
group B were higher than 0.5 for all but three items, indicating
acceptable reliability. Cronbachs alpha was 0.83 for questions
on pain intensity and 0.51 for interference with daily activities.
After two reminders, 2456 patients (86%), in the sample from
the Hernia Register had responded to the questionnaire. In
response to a question about “worst perceived pain last week”,
758 patients (31%) reported pain to some extent. In 144 cases
(6%) the pain interfered with daily activities. CONCLUSION:
The validity and reliability is sufﬁcient to make IPQ a useful
instrument in the routine assessment of post-herniorrhaphy pain.
Disabling pain was found to be a widespread problem 3 years
after surgery.
RESPIRATORY DISEASES—Clinical Outcomes Studies
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OBJECTIVES: Asthma and chronic obstructive pulmonary
disease (COPD) present health concerns and an economic burden
for patients and managed care plans. This study compares uti-
lization outcomes in patients with COPD, asthma or co-
occurring COPD and asthma in a Medicaid population.
METHODS: We queried all medical and pharmacy claims of
Medicaid patients with COPD and/or asthma ﬁled between
January 1, 20001 and December 31, 2003, from encounter data.
COPD patients were identiﬁed based on at least one claim with
ICD-9 codes 491, 492, 496, and asthma patients on the basis of
ICD-9 code 493 as primary, secondary or tertiary diagnosis. We
analyzed annual utilization attributable to COPD and/or asthma,
and compared relative utilization of hospitalizations, physician,
outpatient and emergency room visits as well as drug prescrip-
tions. RESULTS: The analysis included a total of 3455 COPD,
3072 asthma and 2604 COPD/asthma patients, and showed 
statistically signiﬁcant differences in the use of services.
COPD/asthma co-occurring disease has higher utilization of any
service type than either disease alone. Compared with asthma,
COPD has higher use of hospitalizations (p < 0.0001), and less
out-patient services (p < 0.0001) and outpatient-emergency visits
(p < 0.0001). Logistic regression results suggest that COPD
patients were 16%-51% more likely to use physician visits (OR
= 1.16, 95% CI: 1.01–1.34) and inpatient services (OR = 1.51
95% CI: 1.31–1.74) and less likely to use out-patient services
(OR = 0.40 95% CI: 0.35–0.46). COPD and asthma co-occur-
ring patients had higher utilization of all services compared with
asthma patients. CONCLUSION: Our data suggest that COPD
and COPD/asthma co-occurring patients were sicker and used
more medical services than asthma patients.
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OBJECTIVES: To review the clinical outcomes of patients hos-
pitalized with chronic obstructive pulmonary disease (COPD)
acute exacerbations in Singapore and to describe the impact of
evidence-based management programs. METHODS: A retro-
spective review was designed for COPD exacerbations patients
admitted from year 2000 to 2005 in three public hospitals in 
Singapore. Adult patients aged 40 years and above with COPD
as the primary reason for hospitalization were retrieved from
computerized database. The outcomes studied included average
hospital length of stay (LOS), in-hospital mortality rate and read-
mission rates within 15 days, 30 days and 90 days. Univariate
ANOVA and Chi-square test, multivariate regression models and
trend analysis were applied to generate statistical results.
RESULTS: Among all 2996 COPD patients, 78.8% were male
(95% CI: 77.3–80.3%). Chinese were about 82.4% (95% C.I.:
81.0–83.8%), Indian 6.6% (95% CI: 5.7–7.5%), and Malay
7.8% (95% CI: 6.8–8.8%). Patients aged 60 and above were the
major population, taking up to 90.4% (95% CI: 89.3–91.5%).
From 2000 to 2005 there were signiﬁcant declines in LOS (6–3
days; p < 0.001), and mortality (12.1–3.7%; p < 0.001) rates.
There were also signiﬁcant reduction in readmission rates at 90
days (22.5–13.6%; p < 0.001) but not at 30 days (11.8–8.6%;
p = 0.076) or 15 days (6.5–6.0%; p = 0.218). By multivariate
regression, by controlling other factors, age is a risk factor for
longer hospital LOS (p = 0.02). Elder patients are also more dan-
gerous on in-hospital death (p < 0.001) and readmission within
90 days (p = 0.043). All the readmission rates for male patients
were signiﬁcantly higher than females (p = 0.002, p < 0.001 and
p < 0.001 for 15, 30, and 90 days respectively). CONCLUSION:
In summary, although the study suffers from several limitations,
i.e. lack of controls, confounded by disease severity etc, it has
shown that implementation of goal directed management pro-
grams in COPD patients was associated with positive trends in
reduced hospitalization, hospital mortality and readmission
rates.
RESPIRATORY DISEASES—Cost Studies
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OBJECTIVES: The costs of respiratory tract infections are con-
siderable. The purpose of this study was to estimate the direct
